Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Paroxysmal movement disorders - practical update on diagnosis and management.

De Gusmao CM, Silveira-Moriyama L.

Expert Rev Neurother. 2019 Sep;19(9):807-822. doi: 10.1080/14737175.2019.1648211. Epub 2019 Aug 8.

PMID:
31353980
2.

The Parkinson's disease and restless legs syndrome/Willis-Ekbom disorder link: evidences, biases and clinical relevance.

Munhoz RP, Constantino MCL, Silveira-Moriyama L.

Arq Neuropsiquiatr. 2019 Jan;77(1):47-54. doi: 10.1590/0004-282X20180125.

3.

Association of Severe Hydrocephalus With Congenital Zika Syndrome.

van der Linden V, de Lima Petribu NC, Pessoa A, Faquini I, Paciorkowski AR, van der Linden H Jr, Silveira-Moriyama L, Cordeiro MT, Hazin AN, Barkovich AJ, Raybaud C, de Brito Abath M, Ribeiro E, Barros Jucá CE, Aragão MFVV, Coelho Travassos PT, Jungmann P.

JAMA Neurol. 2019 Feb 1;76(2):203-210. doi: 10.1001/jamaneurol.2018.3553.

4.

Relationship of socioeconomic status to olfactory function.

Fornazieri MA, Doty RL, Bezerra TFP, de Rezende Pinna F, Costa FO, Voegels RL, Silveira-Moriyama L.

Physiol Behav. 2019 Jan 1;198:84-89. doi: 10.1016/j.physbeh.2018.10.011. Epub 2018 Oct 15.

PMID:
30336228
5.

Olfactory Function in SCA10.

Moscovich M, Munhoz RP, Moro A, Raskin S, McFarland K, Ashizawa T, Teive HAG, Silveira-Moriyama L.

Cerebellum. 2019 Feb;18(1):85-90. doi: 10.1007/s12311-018-0954-1.

6.

Phenotypes, genotypes, and the management of paroxysmal movement disorders.

Silveira-Moriyama L, Kovac S, Kurian MA, Houlden H, Lees AJ, Walker MC, Roze E, Paciorkowski AR, Mink JW, Warner TT.

Dev Med Child Neurol. 2018 Jun;60(6):559-565. doi: 10.1111/dmcn.13744. Epub 2018 Mar 30. Review.

7.

Endemic atypical parkinsonism.

Silveira-Moriyama L, Lees AJ.

J Neurol Sci. 2018 May 15;388:220-221. doi: 10.1016/j.jns.2018.02.018. Epub 2018 Feb 7. No abstract available.

PMID:
29449009
8.

Genetic Diagnostics for Neurologists.

Silveira-Moriyama L, Paciorkowski AR.

Continuum (Minneap Minn). 2018 Feb;24(1, Child Neurology):18-36. doi: 10.1212/CON.0000000000000556. Review.

PMID:
29432235
9.

Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test.

Morley JF, Cohen A, Silveira-Moriyama L, Lees AJ, Williams DR, Katzenschlager R, Hawkes C, Shtraks JP, Weintraub D, Doty RL, Duda JE.

NPJ Parkinsons Dis. 2018 Jan 15;4:2. doi: 10.1038/s41531-017-0039-8. eCollection 2018.

10.

Dramatic improvement of tardive dyskinesia movements by inline skating.

Casagrande SCB, Cury RG, de Lima-Pardini AC, Coelho DB, Souza CO, Dos Santos Ghilardi MG, Silveira-Moriyama L, Teixeira LA, Barbosa ER, Fonoff ET.

Neurology. 2017 Jul 11;89(2):211-213. doi: 10.1212/WNL.0000000000004092. No abstract available.

PMID:
28696930
11.

Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.

Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Silveira-Moriyama L, Ashizawa T, Teive HAG.

Cerebellum. 2017 Dec;16(5-6):938-944. doi: 10.1007/s12311-017-0869-2.

12.

Neuroplasticity and neuromodulation in children.

Silveira-Moriyama L.

Eur J Paediatr Neurol. 2017 Jan;21(1):3. doi: 10.1016/j.ejpn.2016.11.011. Epub 2016 Dec 7. No abstract available.

PMID:
28010918
13.

The Hitchhiker's guide to the rhinencephalon.

Silveira-Moriyama L, Glass P, Rajan S, Carvalho R, Reis F, Penatti CA, Muio V.

Arq Neuropsiquiatr. 2016 Apr;74(4):329-36. doi: 10.1590/0004-282X20160043. Review.

14.

Testing for haptic perception.

Silveira-Moriyama L, Bella GP.

Arq Neuropsiquiatr. 2016 Jan;74(1):3-4. doi: 10.1590/0004-282X20150206. No abstract available.

15.

Effects of age and cognition on a cross-cultural paediatric adaptation of the Sniffin' Sticks Identification Test.

Bastos LO, Guerreiro MM, Lees AJ, Warner TT, Silveira-Moriyama L.

PLoS One. 2015 Aug 12;10(8):e0131641. doi: 10.1371/journal.pone.0131641. eCollection 2015.

16.

Hyposmia in SWEDD.

Silveira-Moriyama L, Birchall J, Bain P, Lees AJ, Bajaj NP.

Mov Disord. 2015 Sep;30(10):1436-7. doi: 10.1002/mds.26344. Epub 2015 Jul 31. No abstract available.

PMID:
26227990
17.

Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?

Ling H, Kearney S, Yip HL, Silveira-Moriyama L, Revesz T, Holton JL, Strand C, Davey K, Mok KY, Polke JM, Lees AJ.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):633-41. doi: 10.1136/jnnp-2015-310756. Epub 2015 Jul 24.

PMID:
26209716
18.

A field guide to current advances in paediatric movement disorders.

Silveira-Moriyama L, Lin JP.

Curr Opin Neurol. 2015 Aug;28(4):437-46. doi: 10.1097/WCO.0000000000000214. Review.

PMID:
26110804
19.

Clinical Findings and Natural History in Ten Unrelated Families with Juvenile and Adult GM1 Gangliosidosis.

Kannebley JS, Silveira-Moriyama L, Bastos LO, Steiner CE.

JIMD Rep. 2015;24:115-22. doi: 10.1007/8904_2015_451. Epub 2015 Jun 25.

20.

Non-motor signs in Parkinson's disease: a review.

Munhoz RP, Moro A, Silveira-Moriyama L, Teive HA.

Arq Neuropsiquiatr. 2015 May;73(5):454-62. doi: 10.1590/0004-282X20150029. Epub 2015 Apr 17. Review.

21.

Parkinson disease: How reliable are prodromal indicators of Parkinson disease?

Silveira-Moriyama L, Lees AJ.

Nat Rev Neurol. 2015 Jan;11(1):5-6. doi: 10.1038/nrneurol.2014.235. Epub 2014 Dec 16. No abstract available.

PMID:
25511898
22.

Adapting the Sniffin' Sticks olfactory test to diagnose Parkinson's disease in Estonia.

Antsov E, Silveira-Moriyama L, Kilk S, Kadastik-Eerme L, Toomsoo T, Lees A, Taba P.

Parkinsonism Relat Disord. 2014 Aug;20(8):830-3. doi: 10.1016/j.parkreldis.2014.04.012. Epub 2014 Apr 16.

PMID:
24792992
23.

Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease.

Fabbri M, Guedes LC, Coelho M, Simão D, Abreu D, Rosa MM, Silveira-Moriyama L, Ferreira JJ.

Eur J Neurol. 2015 Jan;22(1):207-10. doi: 10.1111/ene.12396. Epub 2014 Mar 6.

PMID:
24602222
24.

PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Hardy J, Giovannoni G, Nageshwaran S, Osborne C, Lees AJ, Schrag A.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):31-7. doi: 10.1136/jnnp-2013-305420. Epub 2013 Jul 4.

25.

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?

Doherty KM, Davagnanam I, Molloy S, Silveira-Moriyama L, Lees AJ.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1400-3. doi: 10.1136/jnnp-2012-304700. Epub 2013 Mar 26.

26.

Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease.

Munhoz RP, Teive HA, Eleftherohorinou H, Coin LJ, Lees AJ, Silveira-Moriyama L.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):883-7. doi: 10.1136/jnnp-2012-304440. Epub 2013 Mar 5.

PMID:
23463867
27.

Parkin disease: a clinicopathologic entity?

Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, Ahmed Z, Brett FM, Hardy J, Quinn N, Counihan TJ, Lynch T, Fox ZV, Revesz T, Lees AJ, Holton JL.

JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.

28.

Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.

Silveira-Moriyama L, Gardiner AR, Meyer E, King MD, Smith M, Rakshi K, Parker A, Mallick AA, Brown R, Vassallo G, Jardine PE, Guerreiro MM, Lees AJ, Houlden H, Kurian MA.

Dev Med Child Neurol. 2013 Apr;55(4):327-34. doi: 10.1111/dmcn.12056. Epub 2013 Jan 30.

29.

Availability of olfactory bulb: experience from a British Brain Bank.

Rajan S, Parsons L, Lees AJ, Silveira-Moriyama L.

Arq Neuropsiquiatr. 2013 Feb;71(2):110-2. Epub 2013 Jan 8.

30.

Opsoclonus myoclonus syndrome associated with GQ1b antibodies.

Morales-Briceño H, Rodríguez-Violante M, Cervantes-Arriaga A, Irani SR, Lees AJ, Silveira-Moriyama L.

Mov Disord. 2012 Nov;27(13):1615-6. doi: 10.1002/mds.25169. No abstract available.

PMID:
23192922
31.

MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy.

Petrovic IN, Martin-Bastida A, Massey L, Ling H, O'Sullivan SS, Williams DR, Holton JL, Revesz T, Ironside JW, Lees AJ, Silveira-Moriyama L.

J Neurol. 2013 Apr;260(4):1031-6. doi: 10.1007/s00415-012-6752-7. Epub 2012 Nov 21. Review.

PMID:
23180183
32.

PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.

Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, Schneider SA, Wali GM, Counihan T, Schapira AH, Spacey SD, Valente EM, Silveira-Moriyama L, Teive HA, Raskin S, Sander JW, Lees A, Warner T, Kullmann DM, Wood NW, Hanna M, Houlden H.

Neurology. 2012 Nov 20;79(21):2115-21. doi: 10.1212/WNL.0b013e3182752c5a. Epub 2012 Oct 17.

33.

Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A.

Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15. Review.

34.

The clinical features of pathologically confirmed vascular parkinsonism.

Glass PG, Lees AJ, Bacellar A, Zijlmans J, Katzenschlager R, Silveira-Moriyama L.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1027-9. doi: 10.1136/jnnp-2012-302828.

PMID:
22960987
35.

Olfactory impairment in familial ataxias.

Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, Ranvaud R, Liu J, McFarland K, Ashizawa T, Lees AJ, Silveira-Moriyama L.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):970-4. doi: 10.1136/jnnp-2012-302770. Epub 2012 Jul 11.

36.

Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?

Stockner H, Schwingenschuh P, Djamshidian A, Silveira-Moriyama L, Katschnig P, Seppi K, Dickson J, Edwards MJ, Lees AJ, Poewe W, Bhatia KP.

Mov Disord. 2012 Aug;27(9):1182-5. doi: 10.1002/mds.25102. Epub 2012 Jun 28.

37.

Tricks of the trade.

Silveira-Moriyama L, Lees AJ.

Arq Neuropsiquiatr. 2012 Apr;70(4):245. No abstract available.

38.

Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease.

Xiromerisiou G, Houlden H, Sailer A, Silveira-Moriyama L, Hardy J, Lees AJ.

Mov Disord. 2012 Sep 1;27(10):1323. doi: 10.1002/mds.24924. Epub 2012 Apr 4. No abstract available.

39.

Camptocormia: don't forget muscle disease in the movement disorder clinic.

Doherty KM, Silveira-Moriyama L, Giladi N, Bhatia KP, Parton M, Lees AJ.

J Neurol. 2012 Aug;259(8):1752-4. doi: 10.1007/s00415-012-6448-z. Epub 2012 Feb 17. No abstract available.

PMID:
22349871
40.

Severe dysphagia as a presentation of Parkinson's disease.

Noyce AJ, Silveira-Moriyama L, Gilpin P, Ling H, Howard R, Lees AJ.

Mov Disord. 2012 Mar;27(3):457-8. doi: 10.1002/mds.24006. Epub 2011 Dec 9. No abstract available.

PMID:
22161964
41.

Screening for VPS35 mutations in Parkinson's disease.

Sheerin UM, Charlesworth G, Bras J, Guerreiro R, Bhatia K, Foltynie T, Limousin P, Silveira-Moriyama L, Lees A, Wood N.

Neurobiol Aging. 2012 Apr;33(4):838.e1-5. doi: 10.1016/j.neurobiolaging.2011.10.032. Epub 2011 Dec 7.

42.

Olfaction in pathologically proven patients with multiple system atrophy.

Glass PG, Lees AJ, Mathias C, Mason L, Best C, Williams DR, Katzenschlager R, Silveira-Moriyama L.

Mov Disord. 2012 Feb;27(2):327-8. doi: 10.1002/mds.23972. Epub 2011 Sep 27. No abstract available.

PMID:
21953531
43.

Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.

Ahmed Z, Doherty KM, Silveira-Moriyama L, Bandopadhyay R, Lashley T, Mamais A, Hondhamuni G, Wray S, Newcombe J, O'Sullivan SS, Wroe S, de Silva R, Holton JL, Lees AJ, Revesz T.

Acta Neuropathol. 2011 Oct;122(4):415-28. doi: 10.1007/s00401-011-0857-4. Epub 2011 Jul 21.

PMID:
21773886
44.

Familial camptocormia: from dystonia to myopathy.

Doherty KM, Noyce AJ, Silveira-Moriyama L, Nisbet A, Quinn N, Lees AJ.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):350-1. doi: 10.1136/jnnp.2011.246561. Epub 2011 Jul 15. No abstract available.

PMID:
21764889
45.

Up with the lark: a panoptic view of Parkinson disease.

Silveira-Moriyama L, Lees AJ.

Neurology. 2011 Jul 26;77(4):310-1. doi: 10.1212/WNL.0b013e318227065d. Epub 2011 Jul 13. No abstract available.

PMID:
21753169
46.

Postural deformities in Parkinson's disease.

Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, Bloem BR.

Lancet Neurol. 2011 Jun;10(6):538-49. doi: 10.1016/S1474-4422(11)70067-9. Epub 2011 Apr 22. Review.

PMID:
21514890
47.

Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil.

Silveira-Moriyama L, Azevedo AM, Ranvaud R, Barbosa ER, Doty RL, Lees AJ.

Arq Neuropsiquiatr. 2010 Oct;68(5):700-5.

48.

Use of smell test identification in Parkinson's disease in Mexico: a matched case-control study.

Rodríguez-Violante M, Lees AJ, Cervantes-Arriaga A, Corona T, Silveira-Moriyama L.

Mov Disord. 2011 Jan;26(1):173-6. doi: 10.1002/mds.23354. Epub 2010 Sep 14.

PMID:
20842690
49.

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.

Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ.

Mov Disord. 2010 Nov 15;25(15):2508-15. doi: 10.1002/mds.23305.

PMID:
20818670
50.

Olfactory heterogeneity in LRRK2 related Parkinsonism.

Silveira-Moriyama L, Munhoz RP, de J Carvalho M, Raskin S, Rogaeva E, de C Aguiar P, Bressan RA, Felicio AC, Barsottini OG, Andrade LA, Chien HF, Bonifati V, Barbosa ER, Teive HA, Lees AJ.

Mov Disord. 2010 Dec 15;25(16):2879-83. doi: 10.1002/mds.23325.

PMID:
20818658

Supplemental Content

Loading ...
Support Center